403 related articles for article (PubMed ID: 19188697)
1. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
2. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.
Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ
Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
4. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
5. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
6. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
7. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
8. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells.
Varley H; Pickett HA; Foxon JL; Reddel RR; Royle NJ
Nat Genet; 2002 Mar; 30(3):301-5. PubMed ID: 11919561
[TBL] [Abstract][Full Text] [Related]
10. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
11. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
[TBL] [Abstract][Full Text] [Related]
12. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms of telomere maintenance exist in liposarcomas.
Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
[TBL] [Abstract][Full Text] [Related]
14. A novel telomere structure in a human alternative lengthening of telomeres cell line.
Marciniak RA; Cavazos D; Montellano R; Chen Q; Guarente L; Johnson FB
Cancer Res; 2005 Apr; 65(7):2730-7. PubMed ID: 15805272
[TBL] [Abstract][Full Text] [Related]
15. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres.
Akimcheva S; Zellinger B; Riha K
Cytogenet Genome Res; 2008; 122(3-4):388-95. PubMed ID: 19188710
[TBL] [Abstract][Full Text] [Related]
16. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
17. Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma.
Omori Y; Nakayama F; Li D; Kanemitsu K; Semba S; Ito A; Yokozaki H
Cancer Sci; 2009 Mar; 100(3):413-8. PubMed ID: 19154407
[TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
19. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
20. Telomere maintenance by recombination in human cells.
Dunham MA; Neumann AA; Fasching CL; Reddel RR
Nat Genet; 2000 Dec; 26(4):447-50. PubMed ID: 11101843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
